Ethical approval to conduct the study was obtained from the Kilimanjaro Christian Medical University College Ethical Committee (Ethical approval number 2039). Permission to carry out the study was obtained from the District Medical Officer (DMO) of Moshi Municipality and in-charge of selected health facilities. Written, informed consent was obtained from each participant. Confidentiality with regards to the information of the participants was highly maintained as no names appeared on the questionnaires. Participants who did not want to participate were not denied access to services at the health facilities. Participants with raise FBG of 7 mmol/L were referred to the diabetes clinic of their respective facility for further evaluation and management.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.